<< NHS teams up with international staff engagement specialists to improve patient care | Report on top 100 European manufacturers of finished pharmaceuticals >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Norsk | Русский | Svenska | Polski

New market research report on pain management drugs

Published on December 7, 2009 at 5:14 AM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/57e412/analgesics_a_wor) has announced the addition of the "Analgesics - A Worldwide Market Intelligence Report" report to their offering.

An aging baby boomer population and subsequent rise in geriatric population, and rising therapeutic benefits of pain treatment drugs (internal) are major factors driving growth in the global analgesics market.

Expanding number of surgical procedures, and longer life of patients suffering from chronic illnesses such as cancer and AIDS further contribute to increased demand for analgesics.

The market is characterized by the presence of a large number of patent-expired products.

Dynamics of the pain management drugs market witnessed significant changes in recent years.

The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs.

There is a lucrative market for effective analgesics, which do not cause any adverse side effects.

These and other market data and trends are presented in "Analgesics: A Worldwide Market Intelligence Report" by BizAcumen, Inc.

Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

http://www.researchandmarkets.com/research/57e412/analgesics_a_wor

Posted in: Pharmaceutical News

Tags: ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading